TheraRadar
Clinical-Stage Companies / Dexa Medica Group

Dexa Medica Group

Pre-Approval PRO BETA
31
Total Trials
19
Phase 3
14
Phase 2
0
Recruiting
417
Score

Pipeline by Phase

Phase 3
19
Phase 2
14
Phase 1
5

Therapeutic Focus

Healthy Acute Ischemic Stroke Cough Polycystic Ovary Syndrome (PCOS) Breast Cancer

Clinical Trials (31)

NCT07420491 Phase 3 COMPLETED

The Efficacy and Safety of Reconyl in Acute Cough Treatment

Started: 6/26/2025

NCT06558071 Phase 3 COMPLETED

Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers

Started: 10/21/2024

NCT05248802 Phase 3 COMPLETED

DLBS2411 Treatment For Functional Dyspepsia

Started: 12/9/2022

NCT03367195 Phase 3 TERMINATED

Efficacy and Safety of DLBS2411 in the Management of GERD

Started: 8/16/2018

NCT02262169 Phase 3 TERMINATED

DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers

Started: 10/1/2014

NCT01999686 Phase 3 COMPLETED

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

Started: 10/1/2014

NCT01733459 Phase 3 COMPLETED

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

Started: 3/1/2013

NCT02362984 Phase 3 TERMINATED

DLBS1033 for the Treatment of Acute Ischemic Stroke

Started: 10/1/2014

NCT01645332 Phase 3 COMPLETED

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

Started: 7/1/2012

NCT01790997 Phase 3 COMPLETED

Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

Started: 5/1/2012

NCT01472614 Phase 3 COMPLETED

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

Started: 9/1/2011

NCT01531933 Phase 3 COMPLETED

Efficacy and Safety of DLBS3233 in Prediabetic Patients

Started: 11/1/2011

NCT06497439 Phase 2 COMPLETED

Efficacy and Safety of Silfamin for Common Cold

Started: 7/12/2024

NCT06558006 Phase 2 COMPLETED

Safety and Efficacy Predimenol for Headache

Started: 6/19/2024

NCT06510257 Phase 2 COMPLETED

Safety and Efficacy Reconyl for Cough With/Without Sore Throat

Started: 7/23/2024

NCT06127225 Phase 2 COMPLETED

Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)

Started: 4/28/2023

NCT02133521 Phase 2 TERMINATED

DLBS1033 for Acute Ischemic Stroke Patients

Started: 11/11/2014

NCT02976701 Phase 2 TERMINATED

Effect of DLBS1033 After Primary PCI in Patients With STE-ACS

Started: 11/1/2016

NCT01942122 Phase 2 COMPLETED

DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis

Started: 10/1/2015

NCT02145988 Phase 2 TERMINATED

DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease

Started: 6/3/2015

NCT01972477 Phase 2 WITHDRAWN

DLBS1449 in Diabetic Patients With Low HDL

Started: 7/1/2016

NCT02146664 Phase 2 WITHDRAWN

DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization

Started: 11/1/2015

NCT01433562 Phase 2 COMPLETED

Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients

Started: 8/1/2011

NCT01006785 Phase 2 TERMINATED

Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer

Started: 8/1/2009

NCT01005069 Phase 2 COMPLETED

Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus

Started: 10/1/2009

NCT06817811 Phase 1 COMPLETED

Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet

Started: 4/15/2021

NCT06558058 Phase 1 COMPLETED

Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets

Started: 6/8/2023

NCT06558032 Phase 1 COMPLETED

Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets

Started: 11/6/2023

NCT06558045 Phase 1 COMPLETED

Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets

Started: 7/6/2023

NCT01573403 Phase 1 COMPLETED

Efficacy and Safety of DLBS2411 in Healthy Volunteers

Started: 4/1/2012

NCT01865474 Phase 4 COMPLETED

Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

Started: 5/1/2013

Drug Candidates

Reconyl Placebo of Reconyl Galatonol 300 mg/Striatin 30 mg Placebo Placebo caplet of DLBS2411 DLBS2411 Apixaban 5 mg Film-Coated Tablet (produced by PT Dexa Medica) Eliquis® 5 mg film-coated tablet (Bristol-Myers Squibb Company, Puerto Rico, packed and released by Bristol-Myers Squibb S.r.l., Italy, imported by PT Pfizer Indonesia) Silfamin Placebo tablet of Silfamin
Activity Status: Active
Last Trial Started: 6/26/2025
Last Trial Ended: 10/3/2025
Trials (12 months): 1
Completed Trials: 22
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.